Steven Tucker, MD, FACP, FAMS

Dr. Steven Tucker was trained in Internal Medicine, Hematology, Oncology, and Stem Cell Transplantation at the UCLA Center for Health Sciences. While at UCLA, he studied molecular biology in the laboratory of Dr. Charles Sawyers and joined the UCLA faculty as Assistant Professor of Clinical Medicine in 1999. In 2006 he moved to Singapore to develop a global oncology clinical trials program and has made Singapore his permanent home.

Dr. Tucker is a thought leader in the transformation of healthcare. An alumnus of the FutureMed program at Singularity University (NASA, Ames), he is engaged daily across a broad range of disciplines including genomic and precision medicine, digital and mobile health, wearable technology, and patient engagement and empowerment.

Dr. Tucker is a sought after speaker and consultant to governments, academia, multi-national enterprises, and patient advocacy groups. Dr. Tucker is the Global Health Advisor for Singapore Telecommunications (SingTel), a Clinical Consultant to InVitae, on the Advisory Board of numerous health and data start-ups such as InsideTracker, Clinicast, and Healint.

Dr. Tucker’s active medical practice focuses on the prevention, early diagnosis, and treatment of breast and prostate cancers. In addition to his oncology practice, Tucker Medical has an extensive wellness and longevity focused General Medical practice that emphasizes personalized data-driven plans based upon each patient’s unique biology as well as lifestyle factors.

Before relocating to Singapore, Dr. Tucker was the Director of the Prostate & Genitourinary Oncology Program at The Angeles Clinic & Research Institute in Santa Monica, California, Attending Physician at the Cedars-Sinai Medical Center, a member of the Breast Cancer Faculty at the John Wayne Cancer Institute in Los Angeles, and a Guest Investigator at Rockefeller University. Dr. Tucker has received numerous honors and awards including an ASCO Merit Award, an NIH Commendation, the UCLA ‘STAR’ Program Award, and a Pew Foundation Fellowship. He is a Fellow of both the Singapore Academy of Medicine and the American College of Physicians.

Ming Chu, MD

Research interests: echocardiography, heart failure, radiofrequency ablation for arrhythmia and management of atrial fibrillation

Dr. Chu served as a visiting scholar atWilf Cardiovascular Research Institute, Albert Einstein College of Medicine in 2013. He received his doctorate in cardiology from the Nanjing Medical University in 2018. He is the master instructor of cardiology in Nanjing Medical University.

Dr. Chu currently works as the chief physician of the cardiology department in the First Affiliated Hospital of Nanjing Medical University. He is also the Director of Taizhou Key Laboratory for Intelligent Prevention and Control of Major Chronic Diseases.

Dr. Chu hosted 10 research projects, including1 National Major Science and Technology Project for the Four Major Chronic Diseases and 2 National Natural Science Foundations. He has published over 20 scientific papers in prestigious journals (Nature Medicine, Advanced Science, etc.), 3 invited book chapters, and 5 patents. He has written a book entitled Atrial fibrillation and Stroke.

Dr. Chu has proposed and implemented a digital integrated chronic disease management model, successively establishing provincial and municipal standards for intelligent village clinics in China. The related achievements have been widely reported by national media outlets such as Xinhua News Agency and People's Daily, with interim findings published in Nature Medicine.

His main areas of research include speckle tracing echocardiography, heart failure，radiofrequency ablation for arrhythmia and management of atrial fibrillation in rural areas.